Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Cosmetic Protocol

Myristoyl Pentapeptide-17Complete Dosing & Administration Guide

Keratin-stimulating lipopeptide specifically designed to enhance eyelash and eyebrow growth through hair follicle activation.

Dose Range

0.01%-0.15%%

Frequency

Once daily

Route

Topical

Cycle Length

Ongoing/indefinite

Dosing

How much
do I take?

Timing

Best time to take

Apply Myristoyl Pentapeptide-17 to clean, dry skin. For best results, use consistently at the same time(s) each day. Evening application is often preferred to allow overnight absorption, unless otherwise directed.

With food?

As a topical product, Myristoyl Pentapeptide-17 is not affected by food intake. Apply to clean skin and allow adequate absorption time before covering the area.

If stacking

Myristoyl Pentapeptide-17 should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

  • +You've tolerated the current dose for the recommended period without significant side effects
  • +Therapeutic goals haven't been met at the current dose level
  • +Your healthcare provider recommends dose escalation based on your response
  • +Lab work or clinical assessments support a higher dose

Decrease if

  • -Side effects are bothersome or impacting daily life despite management strategies
  • -You experience any signs of an adverse reaction
  • -Lab results indicate the need for dose reduction
  • -Your healthcare provider recommends a lower dose based on your response

Signs of right dose

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Dosing Calculator

Calculate Your Exact Dose

1
2
3
4

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The weight is on the label

Peptide vial
5mg

Select Weight

mg

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do I
use it?

Reconstitution

What you need

  • Myristoyl Pentapeptide-17 in its prescribed form
  • Clean, dry storage container
  • Measuring device if applicable (oral syringe, measuring cup)
  • Calendar or reminder app for dosing schedule

Example

Myristoyl Pentapeptide-17 comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.

Use Myristoyl Pentapeptide-17 exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.

Injection

Route

Myristoyl Pentapeptide-17 is administered Topical—no injection required

Best sites

  • Not applicable—this is not an injectable formulation

Technique

  • 1.Follow the specific administration instructions for your Myristoyl Pentapeptide-17 formulation
  • 2.Take or apply as directed by your healthcare provider
  • 3.Store properly between uses according to package instructions

Storage

Before reconstitution

Store Myristoyl Pentapeptide-17 in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Myristoyl Pentapeptide-17 should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Sample Daily Schedule

As prescribed (once daily)

As prescribed by your healthcare provider injection

Site: Topical—rotate sites if applicable

Maintain a consistent schedule for optimal results with Myristoyl Pentapeptide-17. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is it
safe?

Safety Profile

Myristoyl pentapeptide-17 demonstrates excellent cosmetic safety with GRAS/safe-for-use status in topical formulations up to 3% concentration. No serious adverse events in 10+ years of cosmetic industry application; mild skin irritation rare (<1%) at recommended concentrations. Dermal penetration limited to epidermis; no systemic absorption in vitro. Well-tolerated in combination with other anti-aging ingredients; photostability adequate for cosmetic formulations.

Clinical cosmetic efficacy studies using non-invasive biophysical measurements (ultrasound elastography, mechanical testing) document skin firmness improvements of 20-25% over 12 weeks. Collagen synthesis quantified via procollagen type I peptide assays shows 2-3 fold increases. Dermatological safety testing per ISO 10993 confirms non-irritant status; no sensitization in repeated insult patch testing (RIPT per OECD 406).

Common Side Effects

Experienced by some users

Mild Tingling at Lash Line

Slight tingling sensation upon application, particularly during the first few uses. Generally benign and transient.

Management: Normal response. Allow product to dry before touching eyes. Reduce application amount if sensation persists.

Temporary Eyelid Dryness

Mild dryness of the eyelid skin may occur during the initial week of treatment.

Management: Apply a gentle eye cream or moisturizer after the peptide serum has been absorbed. Use sparingly at the lash line.

Product Residue Buildup

Some users notice minor flaking or residue at the lash base if product is over-applied.

Management: Use minimal amount — a thin line along the upper lash line is sufficient. Clean lash line gently before reapplication.

Lash Shedding During Initial Phase

Temporary shedding of telogen-phase lashes may occur as the growth cycle resets — similar to the shedding phase seen with other growth treatments.

Management: Normal part of the growth cycle reset. Continue application. New stronger lashes will replace those shed within 2-4 weeks.

Less Common

  • Periorbital Sensitivity

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

  • ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • ×Your healthcare provider recommends discontinuation based on your clinical response
  • ×Development of any new medical condition that may be contraindicated with Myristoyl Pentapeptide-17
  • ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • ×Abnormal lab results or clinical markers that suggest adverse effects

Myristoyl Pentapeptide-17 should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Interactions

With other peptides

  • May be used together under medical guidance.
  • May be used together under medical guidance.
  • May be used together under medical guidance.

With medications

  • !Prostaglandin Analogs (bimatoprost, latanoprost) - Use with caution—discuss with your healthcare provider.
  • !High-concentration Retinoids near the eye - Use with caution—discuss with your healthcare provider.
  • !Waterproof Mascara (directly over wet serum) - Use with caution—discuss with your healthcare provider.

With supplements

  • Multivitamins - Generally safe to take alongside Myristoyl Pentapeptide-17. Space doses apart if taking oral formulations to ensure optimal absorption.
  • Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Want the Full Picture?

View the complete Myristoyl Pentapeptide-17 research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.

View Full Myristoyl Pentapeptide-17 Profile

Medical Disclaimer

Myristoyl Pentapeptide-17 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: 2/8/2026